Search alternatives:
significant benefits » significant effects (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gender decrease » teer decrease (Expand Search)
significant benefits » significant effects (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gender decrease » teer decrease (Expand Search)
-
1
Gender-disaggregated descriptive statistics for demographics, resources, and market factors.
Published 2025Subjects: -
2
Gendered descriptive statistics for socioeconomic capital, insect knowledge, and perception.
Published 2025Subjects: -
3
-
4
-
5
Selection model estimates for gender-specific determinants of participation in cricket farming.
Published 2025Subjects: -
6
-
7
Summary map of all contacts with statistically significant SVM classifications.
Published 2024“…<p>The top row presents the proportion of significant SVM clusters. It illustrates what proportions of channels are significant at that time-frequency ranging from 0 to 1. …”
-
8
-
9
-
10
-
11
-
12
Lecturers by gender.
Published 2025“…Concerning gender, a clear imbalance in favour of men persists among lecturers. …”
-
13
Posters by gender.
Published 2025“…Concerning gender, a clear imbalance in favour of men persists among lecturers. …”
-
14
-
15
-
16
-
17
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
18
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
19
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
20